Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study

Cited by (261)

Items 101–200 of 261

1. Continuous glucose monitoring
   Dana Michelle Lewis, Tamara K. Oser, Benjamin John Wheeler · 2023 · BMJ
2. Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System
   Kota Nishihama, Kazuhito Eguchi, Kanako Maki, Yuko Okano, Soichiro Tanaka, Chisa Inoue, Akihiro Uchida, Mei Uemura, Toshinari Suzuki, Taro Yasuma et al. · 2021 · American Journal of Case Reports
3. Practical Considerations for Using Continuous Glucose Monitoring in Patients with Gestational Diabetes Mellitus
   KRISTIN N. CASTORINO, Celeste P. Durnwald, Stacey Ehrenberg, Nicole M Ehrhardt, Diana Isaacs, Carol Joan Levy, Amy Miyoshi Valent, Continuous Glucose Monitoring for Gestational Diabetes Management Working Group · 2024 · Journal of Women s Health
4. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications
   Lei Zhang, Xiaoxuan Sun, Qingshan Tian · 2024 · Acta Diabetologica
5. Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia
   Sara Charleer, Christophe E.M. De Block, Nancy Bolsens, Liesbeth Van Huffel, Frank R. E. Nobels, Chantal Mathieu, Pieter Gillard · 2023 · Diabetes Technology & Therapeutics
6. Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol
   Francesca De Ridder, Rie Braspenning, J. Ordóñez, Gijs Klarenbeek, Patrick Lauwers, Kristien J. Ledeganck, Danaë Delbeke, Christophe E.M. De Block · 2024 · PLoS ONE
7. National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
   Murphy Murphy · 2021 · The Journal of Family Practice
8. Efficacy of Flash Glucose Monitoring in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
   Bonnie Liang, Digsu N. Koye, Mariam Hachem, Neda Zafari, Sabine Braat, Elif Ilhan Ekinci · 2022 · Frontiers in Clinical Diabetes and Healthcare
9. Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM
   Jerzy Hohendorff, Przemysław Witek, Michał Kania, Maria Sudoł, Katarzyna Hajduk, Adam Stępień, Katarzyna Cyganek, Beata Kieć‐Wilk, Tomasz Klupa, Maciej Tadeusz Malecki · 2022 · Frontiers in Endocrinology
10. Exploring Technology’s Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review
    Reid D. McClure, Meryem Khadija Talbo, Anne Bonhoure, Joséphine Molveau, Courtney A. South, Maha Lebbar, Zekai Wu · 2024 · Current Diabetes Reports
11. Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World
    Judith L Glennie, Lori Berard, Fleur Levrat‐Guillen · 2022 · ClinicoEconomics and Outcomes Research
12. Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?
    Eugene E. Wright, Savitha Subramanian · 2023 · Diabetes Technology & Therapeutics
13. Impact of short-term application of continuous glucose monitoring system(CGMS) on long-term glycemic profile in adolescents and adults with type 1 diabetes mellitus: An open-label randomized control cross over study
    Ashish V Gupta, Soham Mukherjee, Sanjay Kumar Bhadada, Sant Ram, Rimesh Pal, Naresh Kumar Sachdeva, Pinaki R Dutta · 2024 · Diabetes Research and Clinical Practice
14. Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes
    Chloë Aernouts, Sarah P. W. Beldé, Julie Lambrechts, Jonathan Mertens, Kristien J. Ledeganck, Sven Francque, Christophe E.M. De Block · 2024 · Diabetes Obesity and Metabolism
15. Rapid‐acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes
    Christophe E.M. De Block, Jolijn Van Cauwenberghe, Niels Bochanen, Eveline Lia Dirinck · 2022 · Diabetes Obesity and Metabolism
16. A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group on Diabetes and Technology
    Sergio Di Molfetta, Antonio Rossi, Roberta Assaloni, Valentino Cherubini, Agostino Consoli, Paolo Di Bartolo, Vincenzo Guardasole, Andrea Laurenzi, Fortunato Lombardo, Claudio Maffeis et al. · 2022 · Diabetes Research and Clinical Practice
17. Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control
    Annel Lameijer, Julia J. Bakker, Kalvin Kao, Yongjin Xu, Rijk O. B. Gans, Henk J. G. Bilo, Timothy C. Dunn, Peter Ruben van Dijk · 2023 · Diabetes Research and Clinical Practice
18. Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy
    Miller, Eden, Chuang, Joyce S., Roberts, Gregory J., Nabutovsky, Yelena, Virdi, Naunihal, Wright, Eugene E. · 2024 · Diabetes Therapy
19. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
    Jyrki Mustonen, Päivi Rautiainen, Marja‐Leena Lamidi, Piia Lavikainen, Janne A. Martikainen, Tiina K. Laatikainen · 2023 · Acta Diabetologica
20. Global Burden of Diabetic Ketoacidosis
    Viswanathan Mohan, Kenneth Lee · 2025 · Diabetes Technology & Therapeutics
21. Long‐term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real‐world setting in Finnish paediatric and adult individuals with type 1 diabetes
    Heta‐Leena Vallivaara, Hanna A. Leppänen, Jyrki Mustonen, Antti Saari, Janne A. Martikainen, Reeta M. Rintamäki · 2025 · Diabetes Obesity and Metabolism
22. Roadmap to Achieving Continuous Glucose Monitoring Equity: Insights From the T1D Exchange Quality Improvement Collaborative
    Osagie A. Ebekozien · 2023 · Diabetes Spectrum
23. Prediction of Blood Glucose Concentration Based on OptiScanner and XGBoost in ICU
    Chun-Han Lin, Chien‐Liang Liu · 2023 · IEEE Access
24. Effect of switch from flash glucose monitoring to flash glucose monitoring with real-time alarms on hypoglycaemia in people with type 1 diabetes mellitus
    Aarón Gutiérrez Pastor, JA Quesada, MM Soler-Martínez, Concepción Carratalá‐Munuera, Francisco Pomares · 2024 · Primary care diabetes
25. Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion
    Sara Lomelino Pinheiro, Margarida Bastos, Luísa M. Barros, Miguel Melo, Isabel Paiva · 2021 · Acta Diabetologica
26. What does the licensing of teplizumab mean for diabetes care?
    Lauren Marie Quinn, Rabbi Swaby, Danijela Tatović, Parth Narendran, Rachel E.J. Besser, Colin Mark Dayan · 2023 · Diabetes Obesity and Metabolism
27. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring
    Klavs Würgler Hansen, Bo Martin Bibby · 2020 · Journal of Diabetes Science and Technology
28. All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting Continuous Glucose Monitoring Use in Gestational Diabetes Within the Medicaid Population
    Carol Joan Levy, Rodolfo Javier Galindo, Christopher G. Parkin, Jacob Gillis, Nicholas B. Argento · 2023 · Journal of Diabetes Science and Technology
29. Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies
    Sushma Reddy, Calvin C. Wu, Aimée S. José, Jennifer L. Hsieh, Shetal Desai Rautela · 2023 · Clinical Diabetes
30. Glycemic Variability in Pancreatogenic Diabetes Mellitus: characteristics, Risks, Potential Mechanisms, and Treatment Possibilities
    Yuyan Sun, Bing Lu, Yuan-Wen Hu, Yingqi Lv, Shao Zhong · 2024 · International Journal of General Medicine
31. Continuous interstitial glucose monitoring in diabetic and non-diabetic critically ill patients is simple and accurate: comparison with venous, arterial and capillary glucose measurements
    Davide Chiumello, Mattia Passeri, Silvia Coppola, Elena Chiodaroli, Simone Carnier, Marialaura Montante, Tommaso Pozzi, Ilaria Goggi, Francesco Bifari, Umberto Mortola et al. · 2025 · Acta Diabetologica
32. Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective
    Tim Nolan, Marie A. Frazzitta · 2021 · Diabetes Technology & Therapeutics
33. Effectiveness of flash glucose monitoring in patients with type 1 diabetes and recurrent hypoglycemia between early and late stages after flash glucose monitoring initiation
    Macarena Contreras, Alex Mesa, Irene Pueyo, Maria Ines Claro, Camila Milad, Clara Viñals, Daría Roca, Montse Granados, Marga Giménez, Ignacio Conget · 2023 · Journal of Diabetes and its Complications
34. Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective
    Lizheng Shi, Richard Hellmund, Abbott Diabetes Care, Alameda, CA, USA · 2020 · US Endocrinology
35. Primary Prevention of CVD with Aspirin: Benefits vs Risks
    Weisman · 2021 · The Journal of Family Practice
36. Impact of flash glucose monitoring on quality of life and glycaemic control parameters in adults with type 1 diabetes mellitus⋆
    Rebeca Jiménez-Sahagún, Emilia Gómez Hoyos, Gonzalo Díaz-Soto, María de la O Nieto de la Marca, Marta Sánchez Ibáñez, Sofía del Amo Simón, Beatriz Torres, Juan José López Gómez, Esther Delgado García, Ana Ortolá Buigues et al. · 2022 · Endocrinología Diabetes y Nutrición (English ed )
37. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9)
    Sajad Emamipour, Peter Ruben van Dijk, Henk J. G. Bilo, Mireille A. Edens, Onno van der Galiën, Maarten Jacobus Postma, Talitha Feenstra, Job F. M. van Boven · 2022 · Journal of Diabetes Science and Technology
38. Pilot study in human healthy volunteers on the use of magnetohydrodynamics in needle-free continuous glucose monitoring
    Tuuli A. Hakala, Laura K. Zschaechner, Risto T. Vänskä, Teemu A. Nurminen, Melissa Wardale, Jonathan Morina, Zhanna A. Boeva, Reeta Saukkonen, Juha-Matti I. Alakoskela, Kim Pettersson-Fernholm et al. · 2022 · Scientific Reports
39. Practical Application of Continuous Glucose Monitoring in Clinical Practice: Case Studies
    Jeff Unger, Denise Reis Franco · 2023 · Diabetes Technology & Therapeutics
40. Dynamic Interference Testing—Unexpected Results Obtained with the Abbott Libre 2 and Dexcom G6 Continuous Glucose Monitoring Devices
    Hendrick Jensch, Steven John Setford, Nicole Thomé, Geethan Srikanthamoorthy, Lea Weingärtner, Mike Grady, Elizabeth Holt, Andreas Pfützner · 2025 · Sensors
41. Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes
    Eden M Miller, Gregory J. Roberts, Jennifer Joseph, Yelena Nabutovsky, Ignacio J. Reyes, Diana Souto, Naunihal S. Virdi, Irl B. Hirsch · 2022 · American Journal of Medicine Open
42. Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes
    Lixin Guo, Yuxiu Li, Mei Zhang, Xinhua Xiao, Hongyu Kuang, Tao Yang, Xiaofan Jia, Xianbo Zhang · 2023 · Frontiers in Endocrinology
43. Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study
    Ayman Al Hayek, Malak Al Mashali, Mohamed Abdulaziz Al Dawish · 2025 · Journal of Diabetes & Metabolic Disorders
44. Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice
    Carol Wysham, Davida F. Kruger · 2021 · Journal of the Endocrine Society
45. Marked Improvement in A1C Levels After Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Maintained Over 4 Years in Patients With Type 1 Diabetes
    Jyrki Mustonen, Päivi Rautiainen, Marja‐Leena Lamidi, Piia Lavikainen, Janne A. Martikainen, Tiina K. Laatikainen · 2022 · Diabetes Spectrum
46. An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
    Maria Ida Maiorino, Raffaella Buzzetti, Concetta Irace, Luigi Laviola, Nicola Napoli, Dario Pitocco, Katherine Esposito, on behalf of LIVE CGM working group · 2023 · Endocrine
47. The double burden: Navigating type 1 diabetes and obesity
    Nele Steenackers, Alix Feldman, Chantal Mathieu, Jonathan Rosen, Jeannette A. E. Söderberg, Ebaa Al‐Ozairi, Carel Wynand le Roux, Bart Van der Schueren · 2024 · Clinical Obesity
48. The effectiveness of daily humanistic care in pharmaceutical care of patients with type 2 diabetes
    Xue Hui, Yinghua Zhou, Xie Shengxiong, Zeng Qingfa, Guan Ying-jun · 2022 · Medicine · Retracted
49. Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
    Rubelj, Karla · 2021 · Acta Clinica Croatica
50. Intermittently scanned continuous glucose monitoring adoption decreases diabetic ketoacidosis hospitalizations and healthcare costs in adults with type 1 diabetes
    Pablo Rodríguez de Vera Gómez, Beatriz Rodríguez Jiménez, Eduardo Mayoral Sánchez, Francisco Jódar Sánchez, Reyes Ravé García, Guillermo E. Umpierrez, Maria Asunción Martínez‐Brocca · 2025 · Diabetes Research and Clinical Practice
51. Diabetes Technology in Saudi Arabia: Current Status and Future Directions
    Mohammed E. Al‐Sofiani, ABDULHALIM M. ALMURASHI, Nada Ahmed Alagil, Azzam O. Al-Othman, Shahad Y. Al-Faris, Ahmed M. Al-Enzi · 2025 · Journal of Diabetes Science and Technology
52. The effect of visfatin genotype on insulin pump therapy on quality of life in patients with type I diabetes
    Lv Jianjun, Xiaona Liu, Hong Li · 2022 · Cellular and Molecular Biology
53. Continuous Glucose Monitoring: Optimizing Diabetes Care: Executive Summary
    Eden M Miller, James R. Gavin, Davida F. Kruger, Stephen Brunton · 2022 · Clinical Diabetes
54. Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology
    Andreas Pfützner, Barbora Tencer, Boris Stamm, Mandar Mehta, Preeti Sharma, Rustam Gilyazev, Hendrick Jensch, Nicole Thomé, Michael Huth · 2023 · Sensors
55. Comparing Glucose Outcomes Following Face-to-Face and Remote Initiation of Flash Glucose Monitoring in People Living With Diabetes
    Andrew P. Kingsnorth, Caroline Wilson, Pratik Choudhary, Tomás Patrick Griffin · 2023 · Journal of Diabetes Science and Technology
56. Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium
    Margaretha M. Visser, Astrid Van Muylder, Sara Charleer, John J. Isitt, Stéphane Roze, Christophe E.M. De Block, Toon Maes, Gerd Vanhaverbeke, Frank R. E. Nobels, Bart Keymeulen et al. · 2024 · Diabetologia
57. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring: A Follow-Up Analysis Using Real-Life Data
    Monika Reddy, Nick S. Oliver · 2020 · Diabetes Technology & Therapeutics
58. Continuous and Intermittent Glucose Monitoring in 2022
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2023 · Diabetes Technology & Therapeutics
59. Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system
    Carol Wong, Anne de Bray, Naeem Ul Hassan, Ahmed Almohandes, Kyi Zin Thant, Sofia Gill, Dayna Gill, Hayley Forsdick, Alan J. Sinclair, Muhammad Ali Karamat et al. · 2024 · Therapeutic Advances in Endocrinology and Metabolism
60. Intermittent Use of Flash Glucose Monitoring Improves Glycemic Control in Chinese Older Patients with Type 2 Diabetes Mellitus
    Yonghui Hu, Rengna Yan, Yun Shen, Huiqin Li, Jianhua Ma, Xiaofei Su · 2025 · Diabetes Metabolic Syndrome and Obesity
61. Glucose alarms approach with flash glucose monitoring system: a narrative review of clinical benefits
    Márcio Krakauer, Solange Travassos de Figueiredo Alves, Melanie Rodacki, Mônica Andrade Lima Gabbay, André Gustavo Daher Vianna, Mauro Scharf, Rodrigo Nunes Lamounier, Denise Reis Franco, Levimar Rocha Araujo, Luís Eduardo Calliari · 2025 · Diabetology & Metabolic Syndrome
62. Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies
    Richard M. Bergenstal, Naunihal S. Virdi, Farhan Quadri, Shridhara Alva · 2025 · Diabetes Technology & Therapeutics
63. Consenso para el uso de monitoreo de glucosa flash en la población adulta colombiana con diabetes mellitus tipo 1 y 2
    Ana María Gómez Medina, Carlos Augusto Yepes, Andrés Duarte-Osorio, Diana Cristina Henao, Pablo Jaramillo-Parra, Ingrid Stephens-Leal, Olga Milena Paola García-Morales, Claudia Rubio, Vanessa Salej-Durán, Gabriela Monroy et al. · 2022 · Acta Médica Colombiana
64. Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data
    Lisa A. de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten Jacobus Postma, Peter Ruben van Dijk, Talitha Feenstra · 2024 · PharmacoEconomics
65. Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
    Kushner · 2021 · The Journal of Family Practice
66. Remote Pharmacist-Assisted Flash Continuous Glucose Monitoring Improves Glycemic Outcomes in Patients With Poorly Controlled Diabetes: A Retrospective Case Series
    Rick L. Siemens · 2022 · Clinical Diabetes
67. Pharmacy benefit considerations for continuous glucose monitoring acquisition: Vermont Medicaid experience
    Lisa Brouillette Hurteau, Nancy J Hogue · 2023 · Journal of Managed Care & Specialty Pharmacy
68. Practical Diabetes Technology: Overcoming Barriers in the Real World
    Laurel H. Messer, STUART ALAN WEINZIMER · 2021 · Diabetes Technology & Therapeutics
69. Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
    Петерс · 2021 · The Journal of Family Practice
70. Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
    Fleur Levrat‐Guillen, Tara Ghazi · 2022 · Diabetes Therapy
71. Guideline Development for Medical Device Technology: Issues for Consideration
    Tadej Battelino, Frank Chip Brosius, Antonio Ceriello, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa M. Lalic, Nikolaus Marx et al. · 2022 · Journal of Diabetes Science and Technology
72. Addressing Inequity in Continuous Glucose Monitoring Access: Leveraging the Hospital in the Continuum of Care
    Gabriella M. Rickards, Julia C. Harrod, Kayla L. Del Valle, Augusto Enrique Caballero, Nadine E. Palermo, Marie Elizabeth McDonnell · 2024 · Journal of Diabetes Science and Technology
73. Persistent Performance Improvement Using Team Resources and Continuous Glucose Monitoring in Patients With Poorly Controlled Type 2 Diabetes
    Andrew Behnke, Kara S. Lucas, Christopher G. Parkin, Varsha Reddy, Michele Orlowski, Ailene Edwards · 2025 · Diabetes Spectrum
74. Diabetes mellitus and work participation
    Dunya Tomic, Karen E Walker-Bone, Tessa G. Keegel, Ella Zomer, Sophia Zoungas, Dianna J. Magliano · 2025 · Nature Reviews Endocrinology
75. Continuous and Intermittent Glucose Monitoring in 2021
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2022 · Diabetes Technology & Therapeutics
76. Diabetes Mellitus and its Association with Work Patterns and Characteristics: A Narrative Review
    Anna Eleftheriou, Aikaterini Rokou, Evangelia Nena, Νικόλαος Παπάνας · 2024 · Experimental and Clinical Endocrinology & Diabetes
77. Integrating Continuous Dual Glucose-Ketone Monitoring into Clinical Practice
    Eden M Miller, Kevin Miller, Richard M. Bergenstal · 2025 · Diabetes Technology & Therapeutics
78. Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes
    Nick S. Oliver · 2022 · Diabetes Therapy
79. The Effect of Do-It-Yourself Real-Time Continuous Glucose Monitoring on Glycemic Variables and Participant-Reported Outcomes in Adults With Type 1 Diabetes: A Randomized Crossover Trial
    Shekhar Sehgal, Mona M. Elbalshy, Jonathan A. Williman, Barbara C. Galland, Hamish R. Crocket, Rosemary M. Hall, Ryan G. Paul, Robert Leikis, Martin I. de Bock, Benjamin John Wheeler · 2023 · Journal of Diabetes Science and Technology
80. Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused
    Quang Nguyen, Anish Arul Iyyavoo, Christopher G. Parkin · 2022 · Journal of Diabetes Science and Technology
81. Glycemic metrics in Japanese isCGM users – Analysis by diabetes type and therapy
    Wataru Ogawa, Tatsuhiko Urakami, Takashi Kadowaki, Kalvin Kao, Laura Brandner, Kenichiro Shimizu, Timothy C. Dunn · 2024 · Journal of Diabetes Investigation
82. Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE
    Nele Steenackers, Thomas Sparsø, Sara Charleer, Christophe E.M. De Block, Diederik De Cock, Carl Delfin, Chantal Mathieu, Frank R. E. Nobels, Sofia Pazmiño, Jonathan Rosen et al. · 2024 · Diabetes Obesity and Metabolism
83. Impact of the initiation of isCGM soon after type 1 diabetes mellitus diagnosis in adults on glycemic indices and fear of hypoglycemia: a randomized controlled trial
    Jerzy Hohendorff, Agata Grzelka‐Woźniak, Marta Patrycja Wróbel, Michał Kania, Lidia Łapińska, Dominika Rokicka, Dorota Stołtny, Irina Kowalska, Krzysztof Strojek, Dorota Zozulińska‐Ziółkiewicz et al. · 2025 · Frontiers in Endocrinology
84. Use of Glucose Monitoring Devices Among Adults with Diabetes in Germany: Results from Nationwide Surveys Conducted in 2017 and 2021/2022
    Yong Du, Jens Baumert, Maike Buchmann, Reinhard Walter Holl, Christin Heidemann · 2025 · Diabetes Technology & Therapeutics
85. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project
    Francisco Javier Ampudia‐Blasco, Estibaliz Ugarte, Ana Isabel Chico, Jorge Garcı́a-Alemán, Manuel Galan-Barroso · 2022 · Journal of Diabetes Science and Technology
86. Implantación masiva de la monitorización continua de glucosa en personas con diabetes tipo 1 en una Unidad de Diabetes de referencia bajo financiación pública: estrategia y resultados
    Irene Pueyo, Clara Viñals, Alex Mesa, Marga Giménez, Ignacio Conget · 2022 · Endocrinología Diabetes y Nutrición
87. Flash glucose monitoring system in patients with type 1 diabetes in healthcare center in Brazil: real world data from a short-term prospective study
    Alessandra Saldanha de Mattos Matheus, Juliana Brazil Fontes Pascoal, Carolina Alves Cabizuca, Lucianne Righeti Monteiro Tannus, Rafael Seno Guimarães, Diogo M. F. Mattos, Roberta Arnoldi Cobas · 2022 · Archives of Endocrinology and Metabolism
88. Strategy and results of the massive implementation of reimbursed continuous glucose monitoring in people with type 1 diabetes
    Irene Pueyo, Clara Viñals, Alex Mesa, Marga Giménez, Ignacio Conget · 2022 · Endocrinología Diabetes y Nutrición (English ed )
89. Health-Care Disparities in the Use of Diabetes Technologies in the UK
    Katharine D. Barnard-Kelly, Christopher G. Parkin · 2022 · International Journal of Diabetes and Technology
90. Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit
    Charlotte Mark‐Wagstaff, Harshal Deshmukh, Emma G. Wilmot, Neil M Walker, Dennis Barnes, Vernon J. Parfitt, Simon Saunders, Rob Gregory, Pratik Choudhary, Jane Patmore et al. · 2023 · Diabetes Obesity and Metabolism
91. Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes
    Silvija Canecki-Varžić, Ivana Prpić-Kriẑevac, Maja Cigrovski Berković, Dario Rahelić, Ema Schönberger, Marina Gradišer, Ines Bilić-Čurčić · 2023 · Medicina
92. Continuous and Intermittent Glucose Monitoring in 2023
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2024 · Diabetes Technology & Therapeutics
93. Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring versus Traditional Blood Glucose Monitoring Among US Adults with Type 1 Diabetes
    Benjamin Wong, Yalin Deng, Karen L. Rascati · 2021 · Journal of Diabetes Science and Technology
94. Long-Term Health Economic Evaluation of Intermittently Scanned Glucose Monitoring Compared with Self-Monitoring Blood Glucose in a Real-World Setting in Finnish Adult Individuals with Type 1 Diabetes
    Jyrki Mustonen, Päivi Rautiainen, Marja‐Leena Lamidi, Piia Lavikainen, Janne A. Martikainen, Tiina K. Laatikainen · 2024 · Diabetes Technology & Therapeutics
95. A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden
    Jendle, J., Buompensiere, M. I., Holm, A. L., de Portu, S., Malkin, S. J. P., Cohen, O. · 2022 · Diabetes Therapy
96. An educational programme and patient‐reported outcomes using flash glucose monitoring and automated bolus calculation in type 1 diabetes
    LINDA H. RAIMOND, Anna L. Secher, Merete Meldgaard, Adelaide K. Linddal, Anne Grynnerup Skouboe, Kirsten Nørgaard · 2023 · Practical Diabetes
97. Accuracy and Functionality of Select Continuous Glucose Monitoring Systems Are Not Impacted by Implantable Cardioverter Defibrillator Devices
    Dylan Lazar, Michael Tao, William Matievich, Kevin Kastanos, Timothy C. Dunn · 2024 · Journal of Diabetes Science and Technology
98. Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
    Kristof Theys, Sofie Vermander, Lieven Annemans, Christophe E.M. De Block, Michel Paul Hermans, Imke Matthys, Frank R. E. Nobels, Trung T. Nguyen, Vanessa Preumont, Katerina E. Zakrzewska et al. · 2024 · PharmacoEconomics - Open
99. Understanding Continuous Glucose Monitoring
    Renee Murray-Bachmann, Ramya Pendyaia, Teresa Cichosz, Erwin Yeung, Sarah L. Fishman · 2024 · Contemporary Endocrinology
100. Breaking through lag: enhancing intradermal electro-osmotic flow and the future of delay-free continuous glucose monitoring
     Davide Ciarrocchi, Ruben Van den Eeckhoudt, Nurul Izni Rusli, Alessandro Zompanti, Simone Grasso, Lazzaro di Biase, Marco Santonico, Giorgio Pennazza, Irene Taurino · 2026 · Frontiers in Bioengineering and Biotechnology